Drug
Mangoral
Mangoral: highest development phase Phase 3, developed by Ascelia Pharma AB. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Ascelia Pharma AB
Trials
| Drug | Phase | Indication |
|---|---|---|
| Mangoral NCT04119843 | Phase 3 | Known or Suspected Focal Liver Lesions |
Latest
No recent events.
Follow Mangoral on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.